Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States.
J Med Econ. 2022 Jan-Dec;25(1):469-480. doi: 10.1080/13696998.2022.2043634.
J Med Econ. 2022.
PMID: 35184650
Free article.
Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina.
Wurcel V, Scherrer E, Aguiar-Ibanez R, Altuna JI, Carabajal F, Jain S, Baluni G.
Wurcel V, et al. Among authors: baluni g.
Oncol Ther. 2021 Jun;9(1):167-185. doi: 10.1007/s40487-021-00142-8. Epub 2021 Feb 23.
Oncol Ther. 2021.
PMID: 33624271
Free PMC article.
Item in Clipboard
Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection.
Lopez-Vinueza C, Urrego-Reyes J, Gutierrez FRS, Wurcel V, Zhang S, Jiang S, Jiang R, Zambrano Harvey A, Dhankhar P, Sawhney B, Baluni G, Jain S, Bhadra D.
Lopez-Vinueza C, et al. Among authors: baluni g.
Adv Ther. 2023 Jun;40(6):2836-2854. doi: 10.1007/s12325-023-02484-3. Epub 2023 May 2.
Adv Ther. 2023.
PMID: 37129772
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.